In four cases of biopsy proven amyloidosis there was evidence of impaired splenic function. All had absent or grossly reduced splenic uptake on colloid isotope scans and three had haematological changes consistent with hyposplenism. Poor splenic function with a normal sized or enlarged spleen may be a clue to underlying amyloid.
Introduction
Poor splenic function is now an accepted finding in a wide range of systemic disorders including coeliac disease, ulcerative colitis, Crohn's disease, sickle cell disease, primary thrombocythaemia and systemic lupus erythematosis. Recently attention has been drawn to hyposplenism in systemic amyloidosis,'"2 a disease in which the spleen is frequently enlarged. We describe four patients in which hyposplenic features provided useful clues as to the underlying diagnosis.
Patients
The characteristic histological appearances of acellular congophilic birefringent deposits of amyloid were demonstrated by biopsy in all four cases. Table I A fit 60 year old coal miner was referred for investigation as possibly suffering coeliac disease following features of hyposplenism on a routine blood film.
Examination revealed mild hepatomegaly and proteinuria. He has impaired renal function with a creatinine of 236 jimol/l. Liver function tests were abnormal and liver biopsy demonstrated parenchymal amyloid. Small intestinal biopsy was normal, excluding coeliac disease. A monoclonal protein of IgG A type was present in the blood and urine. A99Tc liver scan (Figure 1 ) showed no splenic uptake but the spleen was of normal size on ultrasound scanning.
Discussion
The spleen is commonly and extensively involved in cases of systemic amyloidosis. 3 4 This involvement is commonly of the sheathed arteries and of the reticulum of the Malpighian bodies when it would not be expected to affect spleen function appreciably. However, involvement of the reticulum of the pulp and of the venous sinuses by amyloid would be expected to impair spleen function and this indeed has been reported.2 This latter type of involvement produces the diffuse waxy spleen which is usually enlarged. Most clinical reviews of patients with amyloidosis rarely consider the role of the spleen except to mention splenomegaly and the rare complication of spontaneous splenic rupture. 4 Three of our four patients had peripheral blood film changes of hyposplenism of varying degree with intraerythrocyte inclusions and abnormally shaped erythrocytes. One case actually presented with classical hyposplenic changes suggesting to the haematologist a diagnosis of occult coeliac disease. These blood film appearances are due to defective 'pitting' and 'culling' function of the spleen.6 Presumably amyloid tissue in the pulp produces blockade of the reticulo-endothelial tissue to interfere with 'culling' and causes some narrowing or rigidity of the sinusoidal clefts to interfere with 'pitting'.
All four patients had grossly reduced or absent splenic uptake on conventional 9Tc liver/spleen scans which are dependent on phagocytic clearance of colloid for effective imaging. It is likely that scans which depend on organ blood flow for imaging will demonstrate the spleen normally in amyloid. In coeliac disease the phagocytic impairment whilst causing blood film abnormalities may not be severe enough to affect colloid scans and these patients, at least in remission, have normal liver-spleen Tc-colloid scans.5 Hyposplenism due to repeated infarcts as in monozygous sickle cell disease results in a small spleen on scanning.' Amyloidosis, with the possible exception of sarcoidosis,8 is the only example of hyposplenism occurring with an enlarged spleen.
Reviews of amyloidosis suggest that infection is an identified cause ofdeath in about 10% ofcases. It may be even higher as sudden death is often ascribed a cardiac aetiology but with underlying hyposplenism there may be cases of fulminant sepsis, the equivalent of overwhelming septicaemia seen following splenectomy.9
